about
Adhesively bonded versus non-bonded amalgam restorations for dental cariesEmollients and moisturisers for eczemaNeuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosisAntibiotic use for irreversible pulpitisPiracetam for reducing the incidence of painful sickle cell disease crisesInterventions for rosaceaInterventions for hirsutism (excluding laser and photoepilation therapy alone)Vitamin K supplementation for cystic fibrosisInterventions for the management of submucous cleft palateAcyclovir for treating primary herpetic gingivostomatitisSurgical adjunctive procedures for accelerating orthodontic treatmentSingle crowns versus conventional fillings for the restoration of root-filled teethLow-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell diseaseInterventions for the management of external root resorptionRecombinant growth hormone therapy for cystic fibrosis in children and young adultsDay care versus in-patient surgery for age-related cataractHematopoietic stem cell transplantation for people with ß-thalassaemia majorTopical antifungal treatments for tinea cruris and tinea corporisRoutine neonatal circumcision for the prevention of urinary tract infections in infancySelenium supplementation for Hashimoto's thyroiditisVitamin K supplementation for cystic fibrosisInterventions for female pattern hair lossSingle crowns versus conventional fillings for the restoration of root filled teethBeta2-adrenoceptor agonists for dysmenorrhoeaOral rinses, mouthwashes and sprays for improving recovery following tonsillectomyBotulinum toxin for masseter hypertrophyLow-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell diseaseInterventions for the management of temporomandibular joint osteoarthritisIrrigants for non-surgical root canal treatment in mature permanent teethNeuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosisOral H1 antihistamines as monotherapy for eczemaHistamine H2-receptor antagonists for urticariaInterventions for the management of mandibular fracturesAntibiotic use for irreversible pulpitisAntibacterial agents in composite restorations for the prevention of dental cariesInterventions for hirsutism excluding laser and photoepilation therapyLow-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell diseaseSelenium supplementation for Hashimoto's thyroiditisPercutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patientsRecombinant growth hormone therapy for cystic fibrosis in children and young adults
P50
Q24186041-0322B696-5871-47A6-BE08-4B622AC0CEADQ24186075-CC9793C7-0A7D-4E84-B064-C38014299380Q24186108-8CCD9D9E-1058-4CAD-B4F9-743E79CDABB2Q24186129-B5AC470C-50DA-4A92-A0EC-7BF2F4CC1D89Q24186141-38AC45DF-17DD-4117-8C7A-A46E6D01402EQ24186383-27A76B54-B81E-4422-A248-96A6F1E5B90BQ24186393-6C6C84E2-BC24-4144-98FA-7C6A5047D699Q24186592-5263E2E5-1CC8-4CB9-B0E9-962C83FF4BE0Q24186608-DC19E83C-A306-4D03-A2F7-468CCB30ACCCQ24186612-A5BCDDEE-45B6-44F9-8AF9-0B415407EFB2Q24186929-11DA7374-5375-4B8E-B4FD-97051CBB3A46Q24187003-B9D59008-29DB-4B9C-ABE8-1B09E529377BQ24187057-E8ADE38D-4194-4740-8404-03004E6B23F8Q24187679-AF8F2F24-04E6-4109-AA1B-CCF4D4C60B28Q24187892-6E91F66E-971D-4E63-B6A7-5AA8763FC61EQ24188004-2F58ACD0-A33C-4BF9-90A2-B449F40CAE98Q24193101-CCAEFD1F-4AFD-40E4-9FC8-AF3E5A14DC3EQ24194482-A5AE6E63-E3DD-4943-B0B0-655914E4FB56Q24197530-2CB009FF-87EF-4861-A270-DB0724375DECQ24197615-CE460A38-5104-40A7-9FC2-36E724240D17Q24197634-FE5DB397-7F1B-4A83-ABB4-C416588C7061Q24197667-966BA1FB-D7AD-4D9F-9304-B7BA925A53EFQ24197883-DCBD1AC5-6173-49D8-B60C-8B06E5ADD2D5Q24197985-8CB4FE4E-B98B-4BCE-8F45-76AF0F9CAA78Q24198158-BF187877-79BB-428F-831C-9B5192460F7FQ24198174-28A2C532-F182-4B94-A5F0-DF985A19CD53Q24198964-E2207B99-7631-4EF3-A539-BF4F4EFCDFD7Q24199136-F26422D0-4027-42EA-8306-CD66DF7BA4B3Q24200425-E07B07B5-9BCF-4D15-92A0-A6484987E948Q24200454-A9341EDA-268C-4279-8514-D1A334BC9064Q24200810-EFE33171-A1CC-44BE-ABA7-4A90052A941CQ24201100-8752B36A-54D4-4D4F-84B6-22F5B53D9D18Q24201296-CFAA3F1D-7669-45D0-A9A3-9001F380B523Q24201660-79F6A461-37BE-471D-8961-7C55D7A7B5CDQ24201755-CAD2E256-F664-4481-B1BD-8EC6296E7DA2Q24201916-139B1BAE-6F67-46A6-84E9-1627CB10C152Q24201981-6DDEEC11-D649-4FEF-AC43-3F0A851D88AAQ24202051-47D7B1A2-7BD2-4B3D-9AD6-931F15163AE4Q24202111-EAD5B079-F4A3-499F-978D-2E2877FD6116Q24202203-449894DA-3D39-4D9D-9910-4B7D3EB82ECE
P50
description
physician
@en
wetenschapper
@nl
name
Zbys Fedorowicz
@ast
Zbys Fedorowicz
@en
Zbys Fedorowicz
@es
Zbys Fedorowicz
@fr
Zbys Fedorowicz
@nl
Zbys Fedorowicz
@sl
type
label
Zbys Fedorowicz
@ast
Zbys Fedorowicz
@en
Zbys Fedorowicz
@es
Zbys Fedorowicz
@fr
Zbys Fedorowicz
@nl
Zbys Fedorowicz
@sl
altLabel
Zbigniew
@en
Zbys
@en
prefLabel
Zbys Fedorowicz
@ast
Zbys Fedorowicz
@en
Zbys Fedorowicz
@es
Zbys Fedorowicz
@fr
Zbys Fedorowicz
@nl
Zbys Fedorowicz
@sl
P1053
C-6659-2008
P106
P1153
24775714600
P1960
VUjWruoAAAAJ
P21
P31
P3829
P3835
zbys-fedorowicz
P496
0000-0003-3952-965X
P569
2000-01-01T00:00:00Z